Literature DB >> 17250852

Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.

Ruth O'Hara1, Barbara Sommer, Nate Way, Helena C Kraemer, Joy Taylor, Greer Murphy.   

Abstract

Detection of preclinical cognitive deficits is important for identifying those at greatest risk for such disorders as Alzheimer's disease. However, available neuropsychological measures may not be sufficiently sensitive to preclinical cognitive impairment, particularly in high functioning or younger older adults. This study utilizes a battery of computerized cognitive tests (Cognometer) designed to provide a more sensitive measure of age-related cognitive performance by incorporating speed-of-processing components. Fifty-one community-dwelling older adults were administered the Cognometer battery, which incorporates speed-of-processing components into measures of verbal, spatial and working memory, attention, and visuo-spatial ability. Performance of 18 subjects with the epsilon4 allele was compared to that of 33 subjects without the epsilon4 allele. A brief battery of standard neuropsychological measures was also administered. No significant differences were observed between the two groups with respect to performance on any of the neuropsychological measures. However, with respect to the Cognometer battery, individuals with the epsilon4 allele were significantly slower in performing all the cognitive tasks, with the exception of the visuo-spatial task. With respect to performance, the two genotype groups did not differ significantly except on immediate memory, with the epsilon4 group exhibiting increased errors. Overall, the epsilon4 group was significantly slower in performing all of the Cognometer memory tasks. These findings provide continued support for the negative impact of the epsilon4 allele on cognition and further suggest that speed-of-processing during memory tasks may have the potential to detect subtle cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250852     DOI: 10.1016/j.jpsychires.2006.12.001

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice.

Authors:  Kathryn Nichol; Sean P Deeny; Joseph Seif; Kevin Camaclang; Carl W Cotman
Journal:  Alzheimers Dement       Date:  2009-07       Impact factor: 21.566

2.  Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers.

Authors:  Sean P Deeny; David Poeppel; Jo B Zimmerman; Stephen M Roth; Josef Brandauer; Sarah Witkowski; Joseph W Hearn; Andrew T Ludlow; José L Contreras-Vidal; Jason Brandt; Bradley D Hatfield
Journal:  Biol Psychol       Date:  2008-03-02       Impact factor: 3.251

3.  Trajectories of cognitive decline in Alzheimer's disease.

Authors:  Patricia A Wilkosz; Howard J Seltman; Bernie Devlin; Elise A Weamer; Oscar L Lopez; Steven T DeKosky; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2009-09-28       Impact factor: 3.878

Review 4.  Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease.

Authors:  Ying Wan; Gang Wang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2008-10       Impact factor: 5.203

5.  Race, APOE genotypes, and cognitive decline among middle-aged urban adults.

Authors:  May A Beydoun; Jordan Weiss; Hind A Beydoun; Sharmin Hossain; Ana I Maldonado; Botong Shen; Michele K Evans; Alan B Zonderman
Journal:  Alzheimers Res Ther       Date:  2021-06-30       Impact factor: 6.982

6.  Reaction time and response inhibition in autosomal dominant Alzheimer's disease.

Authors:  Luis D Medina; Ellen Woo; Yaneth Rodriguez-Agudelo; Hector Chaparro Maldonado; Dahyun Yi; Giovanni Coppola; Yan Zhou; Helena C Chui; John M Ringman
Journal:  Brain Cogn       Date:  2020-12-10       Impact factor: 2.682

7.  Possible Association of APOE Genotype with Working Memory in Young Adults.

Authors:  Lindsey I Sinclair; Katherine S Button; Marcus R Munafò; Ian N M Day; Glyn Lewis
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.